Tellgen Corporation

Tellgen Corporation was established in 2003 at the Medicine Valley in Shanghai, also known as the Silicon Valley of China, which went public in 2017 in Shenzhen and grew to 1000 employees. The Tellgen Corporation focuses on tumor markers detection, provide total solution from screening to prognosis evaluation related products for customers. The methodology platform employed including immunofluorescence, chemiluminescence immunoassay and multiple fluorescent PCR, mass spectrometry, etc. Tellgen is one of the global strategic partners with Luminex Corp. Meanwhile, Tellgen is the first one to launch an automated high-throughput immunoassay system (TESMI) based on fluorescence flowcytometry technology. In 2019, we...

体外诊断试剂／仪器研发与销售,ivd,immunoassay,molecular pcr,mass spectrometry,biochemistry,clinical chemistry,modular automation,laboratory automation,clia,chemiluminescence,and chemiluminescent immunoassay

Tellgen corporation operates in the Medical equipment manufacturing industry.

Tellgen corporation's revenue is 11m - 100m

Tellgen corporation has 11 - 50 employees.